Search the Newsreel

Humana Stock Gains 1.1% as 600,000-Member Medicare Reset Tests Its 2028 Margin Plan

Humana (NYSE:HUM) shares rose 1.1% last week as the company navigates a significant Medicare Advantage reset, planning to exit approximately 600,000 members while aiming to retain 40% in other offerings. This strategy is designed to achieve a sustainable pre-tax margin of at least 3% …

Humana, UnitedHealth trim Medicare Advantage on rising costs

Yahoo Finance Senior Columnist Kerry Hannon explains that major health insurers like Humana (HUM) and UnitedHealth Group (UNH) are dropping hundreds of thousands of Medicare Advantage members to protect profit margins as rising utilization drives up costs. Video Transcript 00:00 Josh Medicare Advantage popular …

Brokers Set Expectations for Humana's Q3 Earnings (NYSE:HUM)

Do Wall Street Analysts Like Humana Stock?

A colorful concept image of a scoring system_ Image by Who is Danny via Shutterstock_ Humana Inc. (HUM), headquartered in Louisville, Kentucky, provides medical and specialty insurance products. With a market cap of $46.7 billion, the company offers coordinated health care through health maintenance …

3,146 Shares in Humana Inc. $HUM Purchased by Retireful LLC

Retireful LLC recently acquired 3,146 shares of Humana Inc. (NYSE:HUM) for approximately $1.25 million, making it a new institutional investor in the company. Humana reported strong quarterly earnings, surpassing analyst expectations with $7.61 EPS and $40.89 billion in revenue, representing a 26.2% year-over-year increase. …

TriaGen Wealth Management LLC Purchases New Stake in Humana Inc. $HUM

TriaGen Wealth Management LLC has acquired a new stake in Humana Inc. (NYSE:HUM) during the second quarter, purchasing 3,039 shares valued at approximately $1,207,000. This comes as other institutional investors have also adjusted their holdings in the insurance provider. The article also details recent …

iHuman Inc. Sponsored ADR Class A Financial Disclosures & SEC Filings

CPI | Glenmark to Pay $15.3 Million to Settle Humana Antitrust Claims

Glenmark Pharmaceuticals' U.S. unit has agreed to pay $15.3 million to settle antitrust claims brought by Humana Inc., alleging price fixing and market allocation in the generic-drug industry. This settlement resolves three complaints as part of a broader litigation stretching back to 2016, and …

Can Humana Improve Caregiver Retention With HealthStream Deal?

Humana's Medicaid plan, Humana Healthy Horizons, is partnering with HealthStream in Indiana to enhance the home-care workforce by offering 1,000 Home Health Aide scholarships and deploying advanced training tools. This initiative aims to combat high caregiver turnover, with early results showing improved retention for …

Humana agrees not to reference Teva's Israel ties at US drug trial

Health insurer Humana has agreed not to refer to drugmaker Teva as an Israeli company during an upcoming U.S. drug price-fixing trial. Teva had requested this, arguing that public views on the Gaza war could unfairly prejudice jurors. The agreement highlights the sensitivity of …

Equities Analysts Offer Predictions for Humana Q1 Earnings

Zacks Research has increased its Q1 2027 EPS estimate for Humana to $9.04, maintaining a "Hold" rating, with the full-year consensus at $9.09. Several other firms have also raised price targets or upgraded the stock, though MarketBeat's overall consensus remains "Hold" with an average …

Humana (NYSE:HUM) Downgraded by Zacks Research to "Hold"

Zacks Research has downgraded Humana (NYSE:HUM) from "strong buy" to "hold," projecting Q1 2027 earnings of $9.04 per share. This downgrade comes despite Humana exceeding recent quarterly expectations with EPS of $7.61 and revenue of $40.89 billion. Analyst sentiment remains mixed, with a consensus …

Humana stock (HUM) climbs 3% as 2027 COLA calculations obscure rising medical-cost shortfall

Humana (HUM) stock rose by 3% despite a preliminary 3.1% Social Security COLA for 2027, as the main concern for the Medicare insurer remains rising healthcare expenses, not retiree payments. The company's Q2 2026 results showed increased revenue and adjusted EPS, but a higher …

Humana taps ex-Johns Hopkins exec as Medicaid leader

Humana has appointed James “J.P.” Holland, formerly president and CEO of Johns Hopkins Health Plans, as its new senior vice president and president of Medicaid. This strategic move, effective August 17, is part of a broader leadership transition and aims to bolster Humana's Medicaid …

Glenmark settles Humana antitrust lawsuit for $15.28 million

Glenmark Pharmaceuticals has settled antitrust lawsuits with Humana for $15.28 million, resolving claims related to generic drug pricing dating back to 2016. The company stated that the full settlement amount, including interest, has already been provided for in its financial records, indicating no significant …

News by CNBC TV18 on TradingView, 2026-08-11 — cnbctv:35c78df51094b:0

Glenmark Pharmaceuticals' US subsidiary has agreed to a $15.28 million settlement with Humana Inc. to resolve antitrust lawsuits related to alleged price-fixing and anti-competitive conduct involving generic pharmaceutical products. Glenmark USA denies all allegations, stating the settlement is to avoid uncertainty, and the full …

Humana Healthy Horizons in Indiana Collaborates with HealthStream to Expand and Strengthen Home Care Workforce

Certification Scholarships and Innovative Retention Program Address Critical Health Need INDIANAPOLIS, August 11, 2026--(BUSINESS WIRE)--Humana Healthy Horizons in Indiana, Humana's Medicaid managed care plan, is collaborating with HealthStream (Nasdaq: HSTM), a leading healthcare technology platform company for clinical workforce solutions, to improve the lives …

Humana Inc. (HUM) Investigation: Bronstein, Gewirtz & Grossman, LLC Encourages Investors to Contact the Firm to Learn More About the Investigation

Bronstein, Gewirtz & Grossman, LLC is investigating potential claims against Humana Inc. (NYSE:HUM) for alleged corporate wrongdoing. The firm encourages investors who purchased Humana securities prior to June 27, 2022, and still hold them, to contact them to assist in the investigation. The investigation …

Tamkeen Human Resources Company (TADAWUL:1835) Pays A ر.س1.43 Dividend In Just Four Days

Humana Names James P. Holland President of Medicaid

Humana Inc. (NYSE: HUM) has appointed James "J.P." Holland as Senior Vice President and President of Medicaid, effective August 17. Holland will lead Humana's Medicaid business, which serves over 1.6 million members across 11 states, reporting to Aaron Martin, President of Insurance. He brings …

JPMorgan Chase & Co. Issues Positive Forecast for Humana (NYSE:HUM) Stock Price

Humana’s Incoming Medicaid President Will Lead Business in 11 States

Humana Inc. announced that James “J.P.” Holland will join the company as Senior Vice President and President of Medicaid, effective August 17. In this role, Holland will lead Humana's Medicaid business, which currently serves over 1.6 million members across 11 states. He brings extensive …

James P. Holland to Join Humana as Medicaid President

LOUISVILLE, Ky., August 10, 2026--(BUSINESS WIRE)--Humana Inc. (NYSE: HUM) today announced that James "J.P." Holland will join the company as senior vice president and President of Medicaid, effective August 17. In this role, Holland will lead the company's growing Medicaid business, which currently serves …

Maharah Human Resources Posts Higher H1 Attributable Net Profit, Revenue

Ihuman Inc (IH) Earnings Forecast: Future EPS & Revenue Growth Estimates

This article provides an earnings forecast for Ihuman Inc (IH), including future EPS and revenue growth estimates. It lists current stock information such as market cap and P/E ratio, along with a peer comparison of other software and IT services companies and their analyst …

Bronstein, Gewirtz & Grossman, LLC Encourages Humana Inc. (HUM) Shareholders to Inquire about Securities Investigation

Bronstein, Gewirtz & Grossman, LLC is investigating potential claims on behalf of Humana Inc. (NYSE:HUM) shareholders who purchased securities before June 27, 2022, and continue to hold them. The investigation focuses on whether Humana's officers and/or directors engaged in corporate wrongdoing. The firm encourages …

Humana Inc. $HUM Stock Position Decreased by Gradient Investments LLC

Gradient Investments LLC reduced its stake in Humana Inc. by 31.3% in the second quarter, selling 6,112 shares and retaining 13,408 shares valued at $5.33 million. Despite this, other institutional investors have increased their positions. Humana reported strong quarterly earnings, beating estimates with $7.61 …

180 Wealth Advisors LLC Cuts Stake in Humana Inc. $HUM

180 Wealth Advisors LLC significantly reduced its stake in Humana Inc. (NYSE:HUM) by 83.1% in the second quarter, selling 3,237 shares and retaining 656 shares valued at $260,000. Despite this, other institutional investors increased their positions, and Humana reported strong quarterly earnings of $7.61 …

Humana Inc. (HUM) Stock forecasts

This article provides a brief stock forecast for Humana Inc. (HUM), noting a bullish technical assessment in the intermediate term according to Argus as of August 4, 2026. It also mentions a heavy earnings week for the IT sector, listing several companies scheduled to …

Humana (HUM) Is Up 5.8% After Cutting 2026 EPS Outlook Amid Strong Q2 And Buybacks

In late July 2026, Humana reported higher second-quarter revenue of US$40,867 million and net income of US$694 million, while also confirming completion of a US$276.13 million share repurchase program initiated in February 2024 and announcing two new board appointments, Paul Smith and Frederick Crawford. …

Humana Inc. stock outperforms competitors on strong trading day

Humana Inc. (HUM) shares rose by 4.84% to $385.00 on Friday, marking its third consecutive day of gains. This performance outpaced the broader market, with the S&P 500 Index (SPX) increasing by 0.62% and the Dow Jones Industrial Average (DJIA) rising by 0.28%. The …

Ihuman Inc (IH) Technical Analysis: Support, Resistance, Indicators & Moving Averages

This article provides a technical analysis of Ihuman Inc (IH), detailing its current price momentum score, support and resistance levels, and indicator and moving average readings. It notes that IH is currently suitable for range-bound swing trading, with a resistance at 1.43 and support …

ANTITRUST—E.D. Pa.: Humana’s generic-drug price-fixing claims will proceed to bellwether trial

The article reports that Humana's antitrust claims alleging generic drug price-fixing will proceed to a bellwether trial in the Eastern District of Pennsylvania. This indicates a significant development in the ongoing litigation, allowing a representative case to be tried to gauge potential outcomes for …